Back to discover
Drug

Baicalin

Research stage
Emerging research
RxNorm1440261ChEMBLCHEMBL485818UNII347Q89U4M5
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Baicalin
RxNorm CUI
1440261
ChEMBL ID
CHEMBL485818
UNII
347Q89U4M5

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes7
Carcinoma, Squamous Cell1Flavonoids1Lactic Acid1Mouth Neoplasms1Squamous Cell Carcinoma of Head and Neck1Tumor Escape1Tumor Microenvironment1
Journals, researchers & institutions
Top journals
  • Journal of advanced research1
Leading researchers
  • Chang Y1
  • Cui Y1
  • Hu X1
  • Liu J1
  • Wang X1
  • Wu Y1
  • Zhao W1
Leading institutions
free-text, unnormalised
  • Key Laboratory of Cancer Prevention and Therapy1
  • The Second Hospital of Tianjin Medical University1
  • Tianjin Medical University School and Hospital of Stomatology & Tianjin Key Laboratory of Oral Soft and Hard Tissues Restoration and Regeneration1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature